Statin use in patients with diabetes amid COVID-19 pandemic.

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad

Kow, Chia Siang; Ramachandram, Dinesh Sangarran; Hasan, Syed Shahzad.

Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia. Electronic address: chiasiang_93@hotmail.com.
Ramachandram DS; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia.
Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

Diabetes Metab ; 48(1): 101298, 2022 01.

Article in English | MEDLINE | ID: covidwho-1491932

Subject(s)

COVID-19; Diabetes Mellitus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Diabetes Mellitus/drug therapy; Diabetes Mellitus/epidemiology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Pandemics; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google